Vanguard Portfolio Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$71.6M Buy
2,188,761
+112,344
+5% +$4.04M ﹤0.01% 1617
2026
Q1
$73.4M Buy
+2,076,417
New +$84.5M ﹤0.01% 1546

Other funds holding CNMD

Vanguard Portfolio Management's CNMD Position: Q2 2026 in Review

Vanguard Portfolio Management increased its CONMED (CNMD) stake by 5.4% in Q2 2026, buying an estimated $4.04M and bringing the position to 2,188,761 shares worth $71.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1617.

Vanguard Portfolio Management first reported a position in CNMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $73.4M in Q1 2026. 244 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Vanguard Portfolio Management held 2,188,761 shares of CONMED worth $71.6M as of Q2 2026.
  • Vanguard Portfolio Management bought 112,344 CONMED shares in Q2 2026, an estimated $4.04M.
  • CONMED made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1617 holding.
  • Vanguard Portfolio Management first reported a position in CONMED in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's CONMED position peaked at $73.4M in Q1 2026.
  • 244 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.